IGF2R and Hepatic fibrosis: In accordance with the literature [13,14], the IGF2R-3GK6E peptide-modified nanocomplex demonstrated a significant uptake in the liver, prolonged the half-life of siRNA, and reduced renal clearance, making it a promising siRNA delivery system for the treatment of liver fibrosis.